These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 18840629
21. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J. Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429 [Abstract] [Full Text] [Related]
22. Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population. Adler G, Agnieszka G, Valjevac A, Czerska E, Kiseljakovic E, Salkic NN. Ann Hum Biol; 2015 Apr; 42(6):576-80. PubMed ID: 25357225 [Abstract] [Full Text] [Related]
23. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY. Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376 [Abstract] [Full Text] [Related]
24. The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results. Saour JN, Shoukri MM, Mammo LA. Saudi Med J; 2009 Oct; 30(10):1286-90. PubMed ID: 19838435 [Abstract] [Full Text] [Related]
25. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C. Clin Ter; 2003 Oct; 154(5):299-303. PubMed ID: 14994919 [Abstract] [Full Text] [Related]
26. [Mutation frequencies of the thrombophilic state genes in Uzbekistan]. Sadikova ShE, Karimov KhIa, Muminov ShM, Tulakov RP, Boboev KT. Tsitol Genet; 2008 Oct; 42(6):50-4. PubMed ID: 19253755 [Abstract] [Full Text] [Related]
27. Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients. Celiker G, Can U, Verdi H, Yazici AC, Ozbek N, Atac FB. Clin Appl Thromb Hemost; 2009 Oct; 15(4):415-20. PubMed ID: 18387982 [Abstract] [Full Text] [Related]
28. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Kocak N. Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129 [Abstract] [Full Text] [Related]
30. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia. Bedencic M, Bozic M, Peternel P, Stegnar M. Pathophysiol Haemost Thromb; 2008 Feb; 36(2):58-63. PubMed ID: 19127083 [Abstract] [Full Text] [Related]
31. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis. Eroglu A, Egin Y, Cam R, Akar N. Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947 [Abstract] [Full Text] [Related]
32. Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Dávalos IP, Moran MC, Martínez-Abundis E, González-Ortiz M, Flores-Martínez SE, Machorro V, Sandoval L, Figuera LE, Mena JP, Oliva JM, Tlacuilo-Parra JA, Sánchez-Corona J, Salazar-Páramo M. Blood Cells Mol Dis; 2005 Jan; 35(1):66-9. PubMed ID: 15905108 [Abstract] [Full Text] [Related]
33. Mutations in clotting factors and inflammatory bowel disease. Bernstein CN, Sargent M, Vos HL, Rosendaal FR. Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138 [Abstract] [Full Text] [Related]
34. Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. Behjati R, Modarressi MH, Jeddi-Tehrani M, Dokoohaki P, Ghasemi J, Zarnani AH, Aarabi M, Memariani T, Ghaffari M, Akhondi MA. Ann Hematol; 2006 Apr; 85(4):268-71. PubMed ID: 16450127 [Abstract] [Full Text] [Related]
35. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major. Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M. Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606 [Abstract] [Full Text] [Related]
36. Thrombophilia in infancy: factor V Leiden and MTHFR or factor II double heterozygocity as a risk factor. Koren A, Levin C, Hujirat Y, El-Hasid R, Kutai M, Lanir N, Shalev S, Brenner B. Pediatr Hematol Oncol; 2003 Dec; 20(3):219-27. PubMed ID: 12637218 [Abstract] [Full Text] [Related]
37. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss]. Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R. Akush Ginekol (Sofiia); 2007 Dec; 46(7):10-6. PubMed ID: 18333414 [Abstract] [Full Text] [Related]
38. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes. Hermans MP, Gala JL, Buysschaert M. Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562 [Abstract] [Full Text] [Related]
39. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746 [Abstract] [Full Text] [Related]
40. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M. Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]